A detailed history of Expect Equity LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Expect Equity LLC holds 14,100 shares of HAE stock, worth $879,276. This represents 1.15% of its overall portfolio holdings.

Number of Shares
14,100
Holding current value
$879,276
% of portfolio
1.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$71.16 - $93.38 $1 Million - $1.32 Million
14,100 New
14,100 $1.1 Billion

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.2B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Expect Equity LLC Portfolio

Follow Expect Equity LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Expect Equity LLC, based on Form 13F filings with the SEC.

News

Stay updated on Expect Equity LLC with notifications on news.